Switch to हिंदी

Health, Fitness, Beauty & Diet | Pregnancy & Parenting | Diseases & Home Remedies | TheHealthSite.com

हिंदी
  • Health A-Z
  • Home Remedies
  • Diseases
    • Type 1 Diabetes
    • Type 2 Diabetes
    • Cancer
    • Heart Attack
    • Pneumonia
    • Diseases A-Z
  • Diet & Fitness
    • Weight Management
    • Exercise & Body Building
    • Diet & Recipes
    • Yoga
  • Coronavirus
  • News
  • Pregnancy
    • Conceiving
    • Infertility
    • Labour & Delivery
    • Pregnancy week-by-week
    • Breastfeeding
    • Baby Names
  • Beauty
    • Skin
    • Hair
    • Grooming
  • Photos
  • Videos
Home / Health News / Leprosy drug ‘clofazimine’ may help with at-home Covid treatment

Leprosy drug ‘clofazimine’ may help with at-home Covid treatment

Covid-19 update: Researchers have recently found that leprosy drug may help in the fight against the coronavirus. Here's what you need to know.

By: Arushi Bidhuri   | | Updated: March 17, 2021 11:04 am
Tags: Coronavirus  covid treatment  COVID-19  

Covid-19, the disease caused by the coronavirus, is a debilitating disease that has affected millions of people across the globe. While vaccines are available to fight Covid infection are available, medical professionals are working tirelessly to come up with potential treatments that will help further help in the battle against the microscopic villain. So, the antiviral drug remedesivir, arthritis drug tocilizumab, anti-malarial drug hydroxychloroquine has been included in the treatment for Covid-19 patients. But there might be another drug available that could help treat coronavirus patients with moderate to severe infection. Also Read - Samajwadi Party Chief Akhilesh Yadav Tests COVID-19 Positive; Lucknow Among Worst Hit In Uttar Pradesh

A recent study has found that a drug used to treat leprosy may help combat Covid-19. Leprosy is an infectious disease that causes serious, damaging skin sores and nerve damage in the limbs. For the study, the team tested clofazimine in hamsters that were infected with the coronavirus. Also Read - What Led to The Drastic Decline in UK’s COVID-19 Cases? PM Boris Johnson Says Lockdown



Leprosy Drug Can Aid People With Severe Covid-19

The study published in the journal Nature showed that leprosy drug clofazimine exhibits potent antiviral activities against SARS-Cov-2 that helps prevent inflammation associated with severe Covid. Researcher Sumit Chanda from the Sanford Burnham Prebys in the US said, “Clofazimine is an ideal candidate for Covid-19 treatment. It is safe, affordable, easy to make, taken as a pill and can be made globally available.” Also Read - 4th Coronavirus Wave: Delhi Becomes Worst Hit COVID State With 13,468 Fresh Cases In 24 Hours

“We hope to test clofazimine in Phase 2 clinical trial as soon as possible for people who test positive for Covid-19 but are not hospitalized. Since there is currently no outpatient treatment available for these individuals, clofazimine may help reduce the impact of the disease, which is particularly important now as we see new variants of the virus emerge and against which the current vaccines appear less efficacious,” he added.

The team found that clofazimine reduced the amount of virus in the system, including those animals who were given the drug before they were infected. It was also found that the medicine lowered lung damage and prevented “cytokine storm” – an inflammatory response to SARS-CoV-2 that can be lethal.

It Also Works With The Current Treatment Available

As per the study results, the drug Clofazimine also works synergistically well with remdesivir, which is the current standard-of-care treatment for people who are hospitalized due to Covid-19. These findings suggest that the production of remdesivir, which costly and in limited supply, should be increased.

(with inputs from IANS)

Published : March 17, 2021 10:56 am | Updated:March 17, 2021 11:04 am
Read Disclaimer

COVID-19 resurgence in India: Act decisively now to curb 'second peak', PM Modi tells CMs

COVID-19 resurgence in India: Act decisively now to curb 'second peak', PM Modi tells CMs

COVID-19 vaccine for children: Moderna begins testing on children between 6 months to 12 years old

COVID-19 vaccine for children: Moderna begins testing on children between 6 months to 12 years old

Please Wait. Article Loading ....

Coronavirus Updates

Coronavirus Updates

Stay Informed, Be Safe

  • Sputnik V: How Does This COVID-19 Vaccine Works And Who All Can Take The Jab
  • Samajwadi Party Chief Akhilesh Yadav Tests COVID-19 Positive; Lucknow Among Worst Hit In Uttar Pradesh
  • 4th Coronavirus Wave: Delhi Becomes Worst Hit COVID State With 13,468 Fresh Cases In 24 Hours
  • WHO Chief: Don't let your guard down, the pandemic is a 'long way from over'
  • Health Problems Due To Work From Home and Tips to Stay Fit Amid The Pandemic

Health Calculators

BMI Calculator
bmi Calculator
Ideal Body Weight
ideal body weight
Daily Calorie Intake
Daily calorie intake
Calories Burned
calories burned

Related Stories

Sputnik V: How Does This COVID-19 Vaccine Works And Who All Can Take The Jab

Sputnik V: How Does This COVID-19 Vaccine Works And Who All Can Take The Jab

Samajwadi Party Chief Akhilesh Yadav Tests COVID-19 Positive; Lucknow Among Worst Hit In Uttar Pradesh

Samajwadi Party Chief Akhilesh Yadav Tests COVID-19 Positive; Lucknow Among Worst Hit In Uttar Pradesh

What Led to The Drastic Decline in UK’s COVID-19 Cases? PM Boris Johnson Says Lockdown

What Led to The Drastic Decline in UK’s COVID-19 Cases? PM Boris Johnson Says Lockdown

4th Coronavirus Wave: Delhi Becomes Worst Hit COVID State With 13,468 Fresh Cases In 24 Hours

4th Coronavirus Wave: Delhi Becomes Worst Hit COVID State With 13,468 Fresh Cases In 24 Hours

Does the Ayurveda principle of healing from within work for COVID-19?

Does the Ayurveda principle of healing from within work for COVID-19?

Health News in Hindi

Corornavirus in India: भारत में बेकाबू कोरोना ने तोड़े अब तक के सारे रिकॉर्ड, 1 दिन में आए करीब 2 लाख केस

CBSE Board Exams: सीबीएसई की 10वीं की परीक्षाएं रद्द, 12वीं की परीक्षाएं टली, प्रधानमंत्री के साथ मीटिंग में लिया गया फैसला

Yogi Adityanath: उत्‍तर प्रदेश के मुख्‍यमंत्री योगी आदित्‍यनाथ भी कोरोना पॉजिटिव, खुद को किया आइसोलेट

Chaitra Navratri 2021: नवरात्रि के पहले व्रत में ही हो गई कमजोरी? इन 4 हेल्‍दी चीजों से पाएं दोगुनी ताकत

कोविड-19 के इन लक्षणों को ना करें नज़रअंदाज, देते हैं ये संक्रमण के गम्भीर होने के संकेत, फौरन जाना पड़ सकता है अस्पताल

Read All

Recent Posts

  • Cancer immunotherapy may cause skin-related side effects: Who are most likely to experiencing them?
  • Children who snore frequently may develop behavioural problems: The reason explained
  • Uttar Pradesh Chief Minister Yogi Adityanath Tests Positive For Coronavirus
  • Sputnik V: How Does This COVID-19 Vaccine Works And Who All Can Take The Jab
  • Samajwadi Party Chief Akhilesh Yadav Tests COVID-19 Positive; Lucknow Among Worst Hit In Uttar Pradesh

About The health Site

TheHealthSite.com is India's largest health site with more than 40 lakh unique visitors per month. We focus on fitness, beauty, health, pregnancy and more.

Most popular health and wellness website in India in 2012 at the Website of the year awards.

health@corp.india.com
+91 – 22 – 6697 1234
Landline Phone number 91 – 22 – 2490 0302.

ZEE ENTERTAINMENT ENTERPRISES LTD, 18th floor, A-Wing, Marathon Futurex, N. M. Joshi Marg, Lower Parel, Mumbai, Maharashtra 400013.

Useful Links

  • Weight Loss
  • Keto Diet Tips
  • Skin Care Tips
  • Intermittent Fasting
  • Apple Cider Vinegar
  • Ashwagandha
  • Cancer
  • Pneumonia
  • Diarrhoea
  • Dengue
  • Typhoid
  • Tuberculosis
  • Chickenpox
  • Chikungunya
  • Depression
  • Hepatitis
  • Diabetes
  • Type 2 diabetes
  • Arthritis
  • Swine Flu
  • Baby Names
  • Cough and cold
  • Heart Attack
  • Breast Cancer
  • Ebola Virus
  • Dengue
  • Malaria
  • International Yoga Day
  • Hypotension
  • Heart Failure
  • Asthma
  • Brain Tumour
  • Celebrity Fitness
  • Goitre
  • HIV/AIDS

We respect your privacy

  • Disclaimer
  • Privacy Policy
  • Contact Us
  • Author Profiles

Copyright © 2021 Zee Entertainment Enterprises Limited. All rights reserved.